Vaccine Therapy for Patients With Stage IV Melanoma
Clinical trial NCT00052156 · UNKNOWN
Trial details
- NCT number
- NCT00052156
- Sponsor
- CancerVax Corporation
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 670
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.